Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias


CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

Online
ISSN
1553-3840
See all formats and pricing
More options …

The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes

Farzad Shidfar / Asadollah Rajab / Tayebeh Rahideh / Nafiseh Khandouzi
  • Corresponding author
  • Department of Nutrition and Biochemistry, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sharieh Hosseini / Shahrzad Shidfar
Published Online: 2015-02-10 | DOI: https://doi.org/10.1515/jcim-2014-0021

Abstract

Background: Ginger (Zingiber officinale) is one of the functional foods which contains biological compounds including gingerol, shogaol, paradol and zingerone. Ginger has been proposed to have anti-cancer, anti-thrombotic, anti-inflammatory, anti-arthritic, hypolipidemic and analgesic properties. Here, we report the effect of ginger supplementation on glycemic indices in Iranian patients with type 2 diabetes.

Methods: A double-blind, placebo-controlled, randomized clinical trial was conducted on 20–60 -year-old patients with type 2 diabetes who did not receive insulin. Participants in the intervention and control groups were received 3 g of powdered ginger or placebo (lactose) (in capsules) daily for 3 months. Glycemic indices, total antioxidant capacity (TAC), malondialdehyde (MDA), C-reactive protein (CRP), serum paraoxonase, dietary intake and physical activity were measured at the beginning and end of the study, and after 12 h fasting.

Results: Comparison of the indices after 3 months showed that the differences between the ginger and placebo groups were statistically significant as follows: serum glucose (–19.41±18.83 vs. 1.63±4.28 mg/dL, p<0.001), HbA1c percentage (–0.77±0.88 vs. 0.02±0.16 %, p<0.001), insulin (–1.46±1.7 vs. 0.09±0.34 μIU/mL, p<0.001), insulin resistance (–16.38±19.2 vs. 0.68±2.7, p<0.001), high-sensitive CRP (–2.78±4.07 vs. 0.2±0.77 mg/L, p<0.001), paraoxonase-1 (PON-1) (22.04±24.53 vs. 1.71±2.72 U/L, p<0.006), TAC (0.78±0.71 vs. –0.04±0.29 µIU/mL, p<0.01) and MDA (–0.85±1.08 vs. 0.06±0.08 µmol/L, p<0.001) were significantly different.

Conclusions: This report shows that the 3 months supplementation of ginger improved glycemic indices, TAC and PON-1 activity in patients with type 2 diabetes.

Keywords: ginger; glycemic markers; paraoxonase; type 2 diabetes

References

  • 1.

    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67–74.PubMedGoogle Scholar

  • 2.

    International Diabetes Federation. IDF guideline for management of post meal glucose in diabetes 2011. Brussels: International Diabetes Federation, 2011.Google Scholar

  • 3.

    Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21.PubMedCrossrefGoogle Scholar

  • 4.

    Webb GP. An overview of dietary supplements and functional food in dietary supplements and functional foods. 1st ed. Blackwell Publishing: Oxford, 2006:1–35.Google Scholar

  • 5.

    Langner E, Greifenberg S, Gruenwald J. Ginger: history and use. Adv Ther 1998;15:25–44.PubMedGoogle Scholar

  • 6.

    McKenna DJ, Jones K, Hughes K, Humphrey S. Ginger in botanical medicines, the desk reference for major herbal supplements. 2nd ed. New York, NY: The Haworth Herbal Press, 2002:411–44.Google Scholar

  • 7.

    Bhattacharjee SK. Zingiber Adams (Boehm) Zingiberaceae. In: Bhattachargee SK, editor. Handbook of aromatic plants. India: Pointer Publisher, 2000:473–4.Google Scholar

  • 8.

    Ali BH, Blunden G, Tanira MO, Some Phytochemical NA. Pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008;46:409–20.CrossrefWeb of ScienceGoogle Scholar

  • 9.

    Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002;67:475–8.PubMedCrossrefGoogle Scholar

  • 10.

    Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005;97:227–30.CrossrefPubMedGoogle Scholar

  • 11.

    Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthr Cartilage 2000;8:9–12.CrossrefGoogle Scholar

  • 12.

    Jafri SA, Abass S, Qasim M. Hypoglycemic effect of ginger (Zingiber officinale) in alloxan induced diabetic rats (Rattus norvagicus). Pak Vet J 2011;31:160–2.Google Scholar

  • 13.

    Saraswat M, Suryanarayana P, Paduru Yadagir R, Madhoosudan AP, Nagalla B, Geereddy Bhanuprakash R. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol Vision 2010;16:1525–37.Google Scholar

  • 14.

    Priya Rani M, Padmakumari KP, Sankarikutty B, Lijo-Cherian O, Nisha VM, Raghu KG. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Intl J Food Sci Nutr 2011;62:106–10.Web of ScienceCrossrefGoogle Scholar

  • 15.

    Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Altern Med 2012, Article ID 516870:10.Web of ScienceGoogle Scholar

  • 16.

    Ramudu SK, Korivi M, Kesireddy N, Lee LC, Cheng IS, Kuo CH, et al. Nephroprotective effects of a ginger extract on cytosolic and mitochondrial enzymes against streptozotocin (STZ) induced diabetic complications in rats. Chin J Physiol 2011;54:79–86.Web of ScienceCrossrefGoogle Scholar

  • 17.

    Rice-Evans C, Miller N. Measurement of the antioxidant status of dietary constituents, low density lipoproteins and plasma. Prostaglandins Leukot Essent Fatty Acids 1997;57:499–505.CrossrefPubMedGoogle Scholar

  • 18.

    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19.PubMedCrossrefGoogle Scholar

  • 19.

    Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, et al. Oxidative stress is reduced by the long term use of vitamin E-coated dialysis filters. Kidney Int 1950;2001:1943–50.Google Scholar

  • 20.

    Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylsterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100–6.Google Scholar

  • 21.

    Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 2009;104:366–73.Web of SciencePubMedCrossrefGoogle Scholar

  • 22.

    Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006;77:160–3.PubMedCrossrefGoogle Scholar

  • 23.

    Bhandari U, Kanojia R, Pillai KK. Effects of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005;97:227–30.CrossrefPubMedGoogle Scholar

  • 24.

    Shirdel Z, Mirbadalzadeh R, Madani H. Antiglycemic and hypolipidemic effect of ginger in alloxan induced diabetic rats and compare it with the glibenclamide. Iran J Diabetes Lipid Disord 2009;9:7–15. [in Persian].Google Scholar

  • 25.

    Zhang XF, Tan BK. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin induced diabetic rats. Singapore Med J 2003;41:1–6.Google Scholar

  • 26.

    Mozaffari-Khosravi H, Talaei B, Jalai BA, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 2014;22:9–16.PubMedCrossrefGoogle Scholar

  • 27.

    Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014;65:515–20.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 28.

    Li Y, Tran VH, Duke CC, Roufogalis BD. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Plant Media 2012;78:1549–55.Google Scholar

  • 29.

    Sekiya K, Ohtani A, Kusano S. Enhancement of insulin sensitivity in adipocyte by ginger. Biofactors 2004;22:153–6.CrossrefPubMedGoogle Scholar

  • 30.

    Isa Y, Miyakawa Y, Yanagisawa Mgoto T, Kang MS, Kawada T, et al. 6-Shgoal and 6-gingerol, the pungent of ginger inhibit TNF-α mediated down regulation of adiponectin expression via different mechanism in 3T3-L1 adipocyte. Biochem Biophys Res Commun 2008;373:429–34.PubMedCrossrefGoogle Scholar

  • 31.

    Bordia A, Radhika B, Suryakantham V. Effect of aswagandha, ginger and mulberry on hyperglycemia and hyperlipidemia. Plant Foods Human Nutr 2003;58:1–7.Google Scholar

  • 32.

    Jolad SD, Lantz AM, Guan JC, Chen GI. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 2004;65:1937–54.PubMedCrossrefGoogle Scholar

  • 33.

    Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu R. Neuroprotective effect of ginger on antioxidant enzymes in streptozotocin induced diabetic rats. Food Chem Toxicol 2011;49:893–7.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 34.

    Mahluji S, Ostadrahimi A, Mobasseri M, Ebrahimzadeh V, Payaboo I. Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients. Adv Pharmaceut Bull 2013;3:273–6.Google Scholar

  • 35.

    Lebda MA, Taha NM, Korshom MA, Mandour A, El-Morshedy AM. Biochemical effect of ginger on some blood and liver parameters in male New Zealand rabiits. Online J Anim Feed Res 2012;2:197–202.Google Scholar

  • 36.

    Abdul Hanif H, Murad NA, Wan Ngah WZ, Mohd Yusof YA. Effects of Zingiber officinale on superoxide dismutase, glutathione peroxidase, catalase, glutathione and malondialdehyde content in HepG2 cell line. Malays J Biochem Mol Biol 2005;11:36–41.Google Scholar

  • 37.

    Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S, Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci 2012;17:355–60.PubMedGoogle Scholar

  • 38.

    Connelly PW, Zinman B, Maguire GF, Mamakeesick M, Harris SB, Hegele RA, et al. Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes. J Lipid Res 2009;50:1216–22.Web of ScienceCrossrefPubMedGoogle Scholar

  • 39.

    Shidfar F, Ehramphosh E, Heydari I, Haghighi L, Hosseini SH, Shidfar SH, et al. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women. Int J Food Sci Nutr 2009;60:195–205.PubMedCrossrefWeb of ScienceGoogle Scholar

About the article

Received: 2014-04-18

Accepted: 2014-12-23

Published Online: 2015-02-10

Published in Print: 2015-06-01


Citation Information: Journal of Complementary and Integrative Medicine, Volume 12, Issue 2, Pages 165–170, ISSN (Online) 1553-3840, ISSN (Print) 2194-6329, DOI: https://doi.org/10.1515/jcim-2014-0021.

Export Citation

©2015 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Bindu Jacob and Narendhirakannan R.T.
3 Biotech, 2019, Volume 9, Number 1
[2]
Loren D. Grossman, Robert Roscoe, and Anita R. Shack
Canadian Journal of Diabetes, 2018, Volume 42, Page S154
[3]
José J. van den Driessche, Jogchum Plat, and Ronald P. Mensink
Food & Function, 2018
[4]
Najmeh Maharlouei, Reza Tabrizi, Kamran B. Lankarani, Abbas Rezaianzadeh, Maryam Akbari, Fariba Kolahdooz, Maryam Rahimi, Fariba Keneshlou, and Zatollah Asemi
Critical Reviews in Food Science and Nutrition, 2018, Page 1
[5]
Jie Zhu, Hao Chen, Zhixiu Song, Xudong Wang, and Zhenshuang Sun
Evidence-Based Complementary and Alternative Medicine, 2018, Volume 2018, Page 1
[6]
Paolo Governa, Giulia Baini, Vittoria Borgonetti, Giulia Cettolin, Daniela Giachetti, Anna Magnano, Elisabetta Miraldi, and Marco Biagi
Molecules, 2018, Volume 23, Number 1, Page 105
[7]
Hsin-Yi Lo, Chia-Cheng Li, Feng-Yuan Chen, Jaw-Chyun Chen, Chien-Yun Hsiang, and Tin-Yun Ho
Journal of Agricultural and Food Chemistry, 2017
[8]
Angie Romero, Milena Forero, Luis G. Sequeda-Castañeda, Adriana Grismaldo, José Iglesias, Crispín A. Celis-Zambrano, Ingrid Schuler, and Ludis Morales
Journal of King Saud University - Science, 2017
[9]
Jin Gyu Choi, Sun Yeou Kim, Minsun Jeong, and Myung Sook Oh
Pharmacology & Therapeutics, 2017
[11]
Mohsen Taghizadeh, Narjes Farzin, Sara Taheri, Mahnaz Mahlouji, Hossein Akbari, Fatemeh Karamali, and Zatollah Asemi
Annals of Nutrition and Metabolism, 2017, Volume 70, Number 4, Page 277
[12]
José Lou-Bonafonte, Clara Gabás-Rivera, María Navarro, and Jesús Osada
International Journal of Molecular Sciences, 2017, Volume 18, Number 2, Page 416
[13]
Sadegh Jafarnejad, Seyed Ali Keshavarz, Sepideh Mahbubi, Sadaf Saremi, Arman Arab, Soheil Abbasi, and Kurosh Djafarian
Journal of Functional Foods, 2017, Volume 29, Page 127
[14]
Hany M. El-Bassossy, Ahmed A. Elberry, and Salah A. Ghareib
Journal of Diabetes and its Complications, 2016, Volume 30, Number 6, Page 1008
[15]
Mehran Rahimlou, Zahra Yari, Azita Hekmatdoost, Seyed Moayed Alavian, and Seyed Ali Keshavarz
Hepatitis Monthly, 2016, Volume 16, Number 1

Comments (0)

Please log in or register to comment.
Log in